Palliative and end-of-life care for patients with hematologic malignancies
A El-Jawahri, AM Nelson, TF Gray, SJ Lee… - Journal of Clinical …, 2020 - ascopubs.org
Hematologic malignancies are a heterogeneous group of diseases with unique illness
trajectories, treatment paradigms, and potential for curability, which affect patients' palliative …
trajectories, treatment paradigms, and potential for curability, which affect patients' palliative …
Palliative and End-of-Life Care for Patients With Hematologic Malignancies
A El-Jawahri, AM Nelson, TF Gray, SJ Lee… - Journal of Clinical …, 2020 - cir.nii.ac.jp
抄録< jats: p> Hematologic malignancies are a heterogeneous group of diseases with
unique illness trajectories, treatment paradigms, and potential for curability, which affect …
unique illness trajectories, treatment paradigms, and potential for curability, which affect …
[HTML][HTML] Palliative and End-of-Life Care for Patients With Hematologic Malignancies
A El-Jawahri, AM Nelson, TF Gray, SJ Lee… - Journal of Clinical …, 2020 - ncbi.nlm.nih.gov
Hematologic malignancies are a heterogeneous group of diseases with unique illness
trajectories, treatment paradigms, and potential for curability, which affect patients' palliative …
trajectories, treatment paradigms, and potential for curability, which affect patients' palliative …
Palliative and End-of-Life Care for Patients With Hematologic Malignancies.
A El-Jawahri, AM Nelson, TF Gray, SJ Lee… - Journal of Clinical …, 2020 - europepmc.org
Hematologic malignancies are a heterogeneous group of diseases with unique illness
trajectories, treatment paradigms, and potential for curability, which affect patients' palliative …
trajectories, treatment paradigms, and potential for curability, which affect patients' palliative …
Palliative and End-of-Life Care for Patients With Hematologic Malignancies
A El-Jawahri, AM Nelson, TF Gray… - Journal of clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
Hematologic malignancies are a heterogeneous group of diseases with unique illness
trajectories, treatment paradigms, and potential for curability, which affect patients' palliative …
trajectories, treatment paradigms, and potential for curability, which affect patients' palliative …